Logo image of MPW

MEDICAL PROPERTIES TRUST INC (MPW) Stock Fundamental Analysis

NYSE:MPW - New York Stock Exchange, Inc. - US58463J3041 - REIT - Currency: USD

5.78  -0.12 (-2.03%)

Premarket: 5.76 -0.02 (-0.35%)

Fundamental Rating

2

Overall MPW gets a fundamental rating of 2 out of 10. We evaluated MPW against 129 industry peers in the Diversified REITs industry. Both the profitability and financial health of MPW have multiple concerns. MPW has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

MPW had negative earnings in the past year.
MPW had a positive operating cash flow in the past year.
In multiple years MPW reported negative net income over the last 5 years.
Of the past 5 years MPW 4 years had a positive operating cash flow.
MPW Yearly Net Income VS EBIT VS OCF VS FCFMPW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

1.2 Ratios

MPW has a Return On Assets of -17.48%. This is amonst the worse of the industry: MPW underperforms 96.83% of its industry peers.
Looking at the Return On Equity, with a value of -48.96%, MPW is doing worse than 92.86% of the companies in the same industry.
MPW has a Return On Invested Capital of 0.14%. This is amonst the worse of the industry: MPW underperforms 89.68% of its industry peers.
MPW had an Average Return On Invested Capital over the past 3 years of 2.26%. This is in line with the industry average of 3.15%.
Industry RankSector Rank
ROA -17.48%
ROE -48.96%
ROIC 0.14%
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
MPW Yearly ROA, ROE, ROICMPW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

MPW has a worse Operating Margin (3.91%) than 88.89% of its industry peers.
In the last couple of years the Operating Margin of MPW has declined.
The Gross Margin of MPW (96.76%) is better than 97.62% of its industry peers.
In the last couple of years the Gross Margin of MPW has remained more or less at the same level.
Industry RankSector Rank
OM 3.91%
PM (TTM) N/A
GM 96.76%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.21%
GM growth 5Y-0.12%
MPW Yearly Profit, Operating, Gross MarginsMPW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MPW is destroying value.
The number of shares outstanding for MPW has been increased compared to 1 year ago.
Compared to 5 years ago, MPW has more shares outstanding
MPW has a worse debt/assets ratio than last year.
MPW Yearly Shares OutstandingMPW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
MPW Yearly Total Debt VS Total AssetsMPW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of 0.00, we must say that MPW is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.00, MPW is not doing good in the industry: 79.37% of the companies in the same industry are doing better.
MPW has a debt to FCF ratio of 90.96. This is a negative value and a sign of low solvency as MPW would need 90.96 years to pay back of all of its debts.
MPW has a Debt to FCF ratio (90.96) which is in line with its industry peers.
A Debt/Equity ratio of 1.69 is on the high side and indicates that MPW has dependencies on debt financing.
MPW's Debt to Equity ratio of 1.69 is on the low side compared to the rest of the industry. MPW is outperformed by 67.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.69
Debt/FCF 90.96
Altman-Z 0
ROIC/WACC0.02
WACC6.07%
MPW Yearly LT Debt VS Equity VS FCFMPW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 1.73 indicates that MPW should not have too much problems paying its short term obligations.
MPW has a better Current ratio (1.73) than 73.02% of its industry peers.
MPW has a Quick Ratio of 1.73. This is a normal value and indicates that MPW is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.73, MPW is doing good in the industry, outperforming 73.81% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.73
MPW Yearly Current Assets VS Current LiabilitesMPW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

MPW shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -605.71%.
MPW shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.19%.
MPW shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.11% yearly.
EPS 1Y (TTM)-605.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)14.19%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%-31.13%

3.2 Future

MPW is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.84% yearly.
The Revenue is expected to decrease by -0.56% on average over the next years.
EPS Next Y90.68%
EPS Next 2Y38.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.05%
Revenue Next 2Y0.53%
Revenue Next 3Y1.55%
Revenue Next 5Y-0.56%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MPW Yearly Revenue VS EstimatesMPW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
MPW Yearly EPS VS EstimatesMPW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2

2

4. Valuation

4.1 Price/Earnings Ratio

MPW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MPW is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MPW Price Earnings VS Forward Price EarningsMPW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

91.27% of the companies in the same industry are cheaper than MPW, based on the Enterprise Value to EBITDA ratio.
65.08% of the companies in the same industry are more expensive than MPW, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 34.25
EV/EBITDA 25.2
MPW Per share dataMPW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as MPW's earnings are expected to grow with 38.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.84%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.42%, MPW is a good candidate for dividend investing.
MPW's Dividend Yield is comparable with the industry average which is at 19.13.
MPW's Dividend Yield is rather good when compared to the S&P500 average which is at 2.30.
Industry RankSector Rank
Dividend Yield 5.42%

5.2 History

The dividend of MPW has a limited annual growth rate of 0.77%.
MPW has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.77%
Div Incr Years0
Div Non Decr Years0
MPW Yearly Dividends per shareMPW Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

The earnings of MPW are negative and hence is the payout ratio. MPW will probably not be able to sustain this dividend level.
The dividend of MPW is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-13.67%
EPS Next 2Y38.84%
EPS Next 3YN/A
MPW Yearly Income VS Free CF VS DividendMPW Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

MEDICAL PROPERTIES TRUST INC

NYSE:MPW (3/3/2025, 8:04:00 PM)

Premarket: 5.76 -0.02 (-0.35%)

5.78

-0.12 (-2.03%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-27 2025-02-27/bmo
Earnings (Next)05-07 2025-05-07/bmo
Inst Owners62.86%
Inst Owner Change-4.67%
Ins Owners16.95%
Ins Owner Change-1.49%
Market Cap3.47B
Analysts51.58
Price Target4.65 (-19.55%)
Short Float %39.55%
Short Ratio14.32
Dividend
Industry RankSector Rank
Dividend Yield 5.42%
Yearly Dividend1.03
Dividend Growth(5Y)0.77%
DP-13.67%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-10 2025-03-10 (0.08)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1582.66%
Min EPS beat(2)-2512.24%
Max EPS beat(2)-653.07%
EPS beat(4)1
Avg EPS beat(4)-703.86%
Min EPS beat(4)-2512.24%
Max EPS beat(4)536.49%
EPS beat(8)1
Avg EPS beat(8)-401.52%
EPS beat(12)5
Avg EPS beat(12)-244.5%
EPS beat(16)7
Avg EPS beat(16)-186.59%
Revenue beat(2)1
Avg Revenue beat(2)-1.83%
Min Revenue beat(2)-9.56%
Max Revenue beat(2)5.9%
Revenue beat(4)2
Avg Revenue beat(4)0.19%
Min Revenue beat(4)-9.56%
Max Revenue beat(4)7.24%
Revenue beat(8)3
Avg Revenue beat(8)-1.63%
Revenue beat(12)4
Avg Revenue beat(12)-2.08%
Revenue beat(16)6
Avg Revenue beat(16)-1.17%
PT rev (1m)0%
PT rev (3m)-7.59%
EPS NQ rev (1m)18.99%
EPS NQ rev (3m)-237.25%
EPS NY rev (1m)-284.31%
EPS NY rev (3m)-160.94%
Revenue NQ rev (1m)1.06%
Revenue NQ rev (3m)-7.38%
Revenue NY rev (1m)2.74%
Revenue NY rev (3m)-3.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.41
P/FCF 34.25
P/OCF 11.41
P/B 0.64
P/tB 0.64
EV/EBITDA 25.2
EPS(TTM)-1.77
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)0.17
FCFY2.92%
OCF(TTM)0.51
OCFY8.77%
SpS1.07
BVpS9.06
TBVpS9.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.48%
ROE -48.96%
ROCE 0.17%
ROIC 0.14%
ROICexc 0.14%
ROICexgc 0.14%
OM 3.91%
PM (TTM) N/A
GM 96.76%
FCFM 15.8%
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
ROICexc(3y)2.3%
ROICexc(5y)3.06%
ROICexgc(3y)2.37%
ROICexgc(5y)3.14%
ROCE(3y)2.86%
ROCE(5y)3.79%
ROICexcg growth 3Y-18.2%
ROICexcg growth 5Y-8.69%
ROICexc growth 3Y-18.71%
ROICexc growth 5Y-8.92%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.21%
GM growth 5Y-0.12%
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 1.69
Debt/FCF 90.96
Debt/EBITDA 18.71
Cap/Depr 43.4%
Cap/Sales 31.63%
Interest Coverage 0.06
Cash Conversion 61.75%
Profit Quality N/A
Current Ratio 1.73
Quick Ratio 1.73
Altman-Z 0
F-Score4
WACC6.07%
ROIC/WACC0.02
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-605.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y90.68%
EPS Next 2Y38.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.19%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%-31.13%
Revenue Next Year-5.05%
Revenue Next 2Y0.53%
Revenue Next 3Y1.55%
Revenue Next 5Y-0.56%
EBIT growth 1Y-95.54%
EBIT growth 3Y-28.05%
EBIT growth 5Y-7.83%
EBIT Next Year113.91%
EBIT Next 3Y34.81%
EBIT Next 5YN/A
FCF growth 1Y174.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44.84%
OCF growth 3YN/A
OCF growth 5YN/A